Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
S Heebøll, M Kreuzfeldt, S Hamilton-Dutoit… - Scandinavian journal …, 2016 - Taylor & Francis
Objective “The obesity epidemic” has led to an increase in obesity-related conditions
including non-alcoholic fatty liver disease (NAFLD), for which effective treatments are in …
including non-alcoholic fatty liver disease (NAFLD), for which effective treatments are in …
Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
S Heebøll, M Kreuzfeldt, S Hamilton-Dutoit… - 2016 - pubmed.ncbi.nlm.nih.gov
Objective" The obesity epidemic" has led to an increase in obesity-related conditions
including non-alcoholic fatty liver disease (NAFLD), for which effective treatments are in …
including non-alcoholic fatty liver disease (NAFLD), for which effective treatments are in …
Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
S Heebøll, M Kreuzfeldt, S Hamilton-Dutoit… - Scandinavian Journal …, 2016 - pure.au.dk
Objective" The obesity epidemic" has led to an increase in obesity-related conditions
including non-alcoholic fatty liver disease (NAFLD), for which effective treatments are in …
including non-alcoholic fatty liver disease (NAFLD), for which effective treatments are in …
Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease.
S Heebøll, M Kreuzfeldt, S Hamilton-Dutoit… - 2016 - cabidigitallibrary.org
Objective" The obesity epidemic" has led to an increase in obesity-related conditions
including non-alcoholic fatty liver disease (NAFLD), for which effective treatments are in …
including non-alcoholic fatty liver disease (NAFLD), for which effective treatments are in …
Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease.
S Heebøll, M Kreuzfeldt, S Hamilton-Dutoit… - Scandinavian Journal …, 2016 - europepmc.org
Objective" The obesity epidemic" has led to an increase in obesity-related conditions
including non-alcoholic fatty liver disease (NAFLD), for which effective treatments are in …
including non-alcoholic fatty liver disease (NAFLD), for which effective treatments are in …
[PDF][PDF] Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
S Heebøll, M Kreuzfeldt… - Scandinavian …, 2016 - bengreenfieldlife.com
ABSTRACT Objective ''The obesity epidemic''has led to an increase in obesity-related
conditions including nonalcoholic fatty liver disease (NAFLD), for which effective treatments …
conditions including nonalcoholic fatty liver disease (NAFLD), for which effective treatments …
Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
S Heebøll, M Kreuzfeldt… - Scandinavian …, 2016 - research.regionh.dk
OBJECTIVE:" The obesity epidemic" has led to an increase in obesity-related conditions
including non-alcoholic fatty liver disease (NAFLD), for which effective treatments are in …
including non-alcoholic fatty liver disease (NAFLD), for which effective treatments are in …
[PDF][PDF] Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
S Heebøll, M Kreuzfeldt… - Scandinavian …, 2016 - bengreenfieldlife.com
ABSTRACT Objective ''The obesity epidemic''has led to an increase in obesity-related
conditions including nonalcoholic fatty liver disease (NAFLD), for which effective treatments …
conditions including nonalcoholic fatty liver disease (NAFLD), for which effective treatments …